Restricted HIV-1 diversity and clonal expansion following cytoreductive chemotherapy

• T.J. Henrich,
• E.P. Scully,
• K.S. Hobbs,
• E. Hanhauser,
• L.E. Hogan,
• C.D. Palmer,
• Y.P. Robles,
• K.S. Leadabrand,
• A.S. LaCasce,
• D.R. Kuritzkes

Affiliations

T.J. Henrich

Brigham and Women's Hospital, Boston, MA, USA; University of California San Francisco, San Francisco, CA, USA

E.P. Scully

Ragon Institute of MGH, MIT and Harvard, USA

K.S. Hobbs

Brigham and Women's Hospital, Boston, MA, USA; University of California San Francisco, San Francisco, CA, USA

E. Hanhauser

Brigham and Women's Hospital, Boston, MA, USA; University of California San Francisco, San Francisco, CA, USA

L.E. Hogan

Brigham and Women's Hospital, Boston, MA, USA; University of California San Francisco, San Francisco, CA, USA

C.D. Palmer

Ragon Institute of MGH, MIT and Harvard, USA

Y.P. Robles

Brigham and Women's Hospital, Boston, MA, USA

K.S. Leadabrand

University of California San Francisco, San Francisco, CA, USA

A.S. LaCasce

Dana-Farber Cancer Center, Boston, MA, USA

D.R. Kuritzkes

Brigham and Women's Hospital, Boston, MA, USA